Document is current
Any future updates will be listed below
-
Authors
Kondo, Hiroki
Tanaka, Akihito https://orcid.org/0000-0003-2260-1942
Miyamoto, Shun
Suzuki, Hitomi
Matsumoto, Hikari
Takeda, Shinichiro
Mizutani, Koji
Tagahara, Kensuke
Uno, Hiroto
Furusawa, Kenji
Ishii, Hideki
Murohara, Toyoaki
- License Information
-
More Information
Article History
Received: 14 November 2025
Accepted: 25 March 2026
First Online: 29 April 2026
Declarations
:
: Akihito Tanaka received speaking and lecture fees from Abbott Medical Japan. Hideki Ishii received speaking and lecture fees from Astellas Pharma Inc, AstraZeneca, Daiichi Sankyo Inc and MSD. Toyoaki Murohara received speaking and lecture fees from Bayer Pharmaceutical Co LTD. Toyoaki Murohara received funding grants and speaking and lecture fees from Daiichi Sankyo Co Ltd, Dainippon Sumitomo Pharma Co Ltd, Kowa Co Ltd, MSD, Mitsubishi Tanabe Pharma Corp, Nippon Boehringer Ingelheim Co Ltd, Novartis Pharma Kabushiki Kaisha, Pfizer Japan Inc, Sanofi-aventis and Takeda Pharmaceutical Co Ltd. Toyoaki Murohara received funding grants from Astellas Pharma Inc, Otsuka Pharmaceutical Co Ltd and Teijin Pharma Ltd. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
